These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8370634)

  • 21. Effects of salmon calcitonin suppositories on bone mass and turnover in established osteoporosis.
    Kollerup G; Hermann AP; Brixen K; Lindblad BE; Mosekilde L; Sørensen OH
    Calcif Tissue Int; 1994 Jan; 54(1):12-5. PubMed ID: 8118746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate].
    Campusano C; López JM; Campino C; Cárdenas I; Rojas A
    Rev Med Chil; 2000 Apr; 128(4):387-91. PubMed ID: 10962855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
    Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 5-year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium.
    Reginster JY; Meurmans L; Deroisy R; Jupsin I; Biquet I; Albert A; Franchimont P
    Eur J Clin Invest; 1994 Aug; 24(8):565-9. PubMed ID: 7982445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss.
    Gennari C; Agnusdei D; Montagnani M; Gonnelli S; Civitelli R
    Calcif Tissue Int; 1992 Apr; 50(4):381-3. PubMed ID: 1571851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis.
    Overgaard K; Hansen MA; Dirksen KL; Christiansen C
    Calcif Tissue Int; 1992 Sep; 51(3):184-8. PubMed ID: 1422962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis.
    Thamsborg G; Jensen JE; Kollerup G; Hauge EM; Melsen F; Sorensen OH
    Bone; 1996 Feb; 18(2):207-12. PubMed ID: 8833216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic human calcitonin in postmenopausal osteoporosis: a placebo-controlled, double-blind study.
    Ljunghall S; Gärdsell P; Johnell O; Larsson K; Lindh E; Obrant K; Sernbo I
    Calcif Tissue Int; 1991 Jul; 49(1):17-9. PubMed ID: 1893291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double blind study of intranasal calcitonin for established postmenopausal osteoporosis.
    Kapetanos G; Symeonides PP; Dimitriou C; Karakatsanis K; Potoupnis M
    Acta Orthop Scand Suppl; 1997 Oct; 275():108-11. PubMed ID: 9385282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis.
    Adachi JD; Bensen WG; Bell MJ; Bianchi FA; Cividino AA; Craig GL; Sturtridge WC; Sebaldt RJ; Steele M; Gordon M; Themeles E; Tugwell P; Roberts R; Gent M
    Br J Rheumatol; 1997 Feb; 36(2):255-9. PubMed ID: 9133941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: a longitudinal study.
    Gonnelli S; Cepollaro C; Pondrelli C; Martini S; Rossi S; Gennari C
    Osteoporos Int; 1996; 6(4):303-7. PubMed ID: 8883119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of nasally administered salmon calcitonin in preventing bone loss.
    Christiansen C
    Calcif Tissue Int; 1991; 49 Suppl 2():S14-5. PubMed ID: 1933614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salmon calcitonin in the prevention of bone loss at perimenopause.
    Arnala I; Saastamoinen J; Alhava EM
    Bone; 1996 Jun; 18(6):629-32. PubMed ID: 8806006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of intranasal salmon calcitonin on biochemical parameters of bone turnover in postmenopausal women.
    Balint-Perić LA; Prelević GM; Beslagić Z; Petrović J
    Gynecol Endocrinol; 1994 Dec; 8(4):241-5. PubMed ID: 7709763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures.
    Resch H; Pietschmann P; Willvonseder R
    Calcif Tissue Int; 1989 Oct; 45(4):209-13. PubMed ID: 2509007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Salmon calcitonin in osteoporosis. The effect of intranasal application on bone mineral content and fracture frequency in postmenopausal women with manifest osteoporotic changes].
    Overgaard K; Ravn P; Hansen MA; Christiansen C
    Ugeskr Laeger; 1993 Aug; 155(31):2387-91. PubMed ID: 8346588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Observations on bone mineral metabolism in natural and surgical menopause. Role of synthetic salmon calcitonin and calcium on bone turnover].
    Ferrante B; Isa L; Uderzo A
    Minerva Ginecol; 1993 Mar; 45(3):87-93. PubMed ID: 8332282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of intranasal salmon calcitonin treatment in postmenopausal osteoporosis].
    Kopaliani M
    Georgian Med News; 2005 Apr; (121):38-42. PubMed ID: 15908722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.